Correlation Between Sinopharm Group and Prestige Consumer
Can any of the company-specific risk be diversified away by investing in both Sinopharm Group and Prestige Consumer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sinopharm Group and Prestige Consumer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sinopharm Group Co and Prestige Consumer Healthcare, you can compare the effects of market volatilities on Sinopharm Group and Prestige Consumer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sinopharm Group with a short position of Prestige Consumer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sinopharm Group and Prestige Consumer.
Diversification Opportunities for Sinopharm Group and Prestige Consumer
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Sinopharm and Prestige is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Sinopharm Group Co and Prestige Consumer Healthcare in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prestige Consumer and Sinopharm Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sinopharm Group Co are associated (or correlated) with Prestige Consumer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prestige Consumer has no effect on the direction of Sinopharm Group i.e., Sinopharm Group and Prestige Consumer go up and down completely randomly.
Pair Corralation between Sinopharm Group and Prestige Consumer
Assuming the 90 days horizon Sinopharm Group is expected to generate 1.54 times less return on investment than Prestige Consumer. In addition to that, Sinopharm Group is 1.17 times more volatile than Prestige Consumer Healthcare. It trades about 0.1 of its total potential returns per unit of risk. Prestige Consumer Healthcare is currently generating about 0.18 per unit of volatility. If you would invest 6,550 in Prestige Consumer Healthcare on September 23, 2024 and sell it today you would earn a total of 950.00 from holding Prestige Consumer Healthcare or generate 14.5% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Sinopharm Group Co vs. Prestige Consumer Healthcare
Performance |
Timeline |
Sinopharm Group |
Prestige Consumer |
Sinopharm Group and Prestige Consumer Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Sinopharm Group and Prestige Consumer
The main advantage of trading using opposite Sinopharm Group and Prestige Consumer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sinopharm Group position performs unexpectedly, Prestige Consumer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prestige Consumer will offset losses from the drop in Prestige Consumer's long position.Sinopharm Group vs. AmerisourceBergen | Sinopharm Group vs. Cardinal Health | Sinopharm Group vs. Henry Schein | Sinopharm Group vs. Shanghai Pharmaceuticals Holding |
Prestige Consumer vs. Ross Stores | Prestige Consumer vs. Fast Retailing Co | Prestige Consumer vs. Canon Marketing Japan | Prestige Consumer vs. JIAHUA STORES |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |